Sustainability Reporting in the Biotechnology Sector

Introduction

Sustainability reporting in the biotechnology sector refers to the systematic disclosure of a company's environmental, social and governance (ESG) performance. It enables investors, regulators, employees, patients and the public to understand how biotechnology and pharmaceutical companies manage environmental risks, public health responsibilities, ethical research and corporate governance.

Biotechnology companies may generate hazardous biological waste, consume substantial energy and water, use genetically engineered organisms and conduct clinical trials involving human participants. Therefore, sustainability reporting is important for ensuring transparency, environmental protection, patient safety and responsible scientific innovation.

In India, sustainability reporting is primarily governed by SEBI's Business Responsibility and Sustainability Reporting (BRSR) framework and applicable environmental and corporate laws.

Legal and Regulatory Framework in India

1. SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Regulation 34(2)(f) requires the top 1,000 listed entities by market capitalisation to submit a Business Responsibility and Sustainability Report (BRSR) as part of their annual reports.

Securities and Exchange Board of India+1

2. BRSR Core Framework: SEBI's 2023 framework introduced standardised ESG performance indicators and a phased requirement for assessment or assurance. It covers areas such as greenhouse gas emissions, energy consumption, water management, employee welfare and business ethics.

1689166456465.pdf

3. Companies Act, 2013: Section 134 requires specified disclosures in the Board's Report, while Section 135 establishes corporate social responsibility obligations for companies meeting prescribed financial thresholds.

4. Environment (Protection) Act, 1986: Regulates environmental pollution and provides the basis for rules governing hazardous microorganisms and genetically engineered organisms.

5. National Guidelines on Responsible Business Conduct, 2019: Establish nine principles concerning ethical business conduct, sustainable products, employee welfare, human rights, environmental protection and consumer responsibility.

Sustainability reporting requirements depend on the company's listing status and applicable regulatory thresholds; they do not automatically apply in identical form to every biotechnology business.

Important Case Laws

1. Alembic Pharmaceuticals Ltd. v. Rohit Prajapati (2020) 17 SCC 157

The Supreme Court examined environmental clearances granted retrospectively to pharmaceutical and chemical industries. It held that ex post facto environmental clearance is contrary to the precautionary principle and sustainable development. The Court imposed environmental compensation on the concerned industries. This judgment is particularly relevant to biotechnology and pharmaceutical companies because it emphasises environmental compliance and accountability for industrial operations.

National Digital Library of India

2. Vellore Citizens' Welfare Forum v. Union of India (1996) 5 SCC 647

The Supreme Court recognised the precautionary principle and polluter-pays principle as essential components of Indian environmental law. The case concerned pollution caused by tanneries in Tamil Nadu. Its principles apply to biotechnology companies generating chemical, pharmaceutical or biological waste and support transparent reporting of environmental risks and corrective measures.

3. M.C. Mehta v. Union of India (1987) 1 SCC 395

In the Oleum Gas Leak case, the Supreme Court established the principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities. The judgment is relevant to biotechnology laboratories and manufacturing facilities handling hazardous biological or chemical materials. Companies must take responsibility for industrial risks and resulting harm.

4. Indian Council for Enviro-Legal Action v. Union of India (1996) 3 SCC 212

The Supreme Court reinforced the polluter-pays principle and held that industries responsible for environmental damage could be required to bear the costs of restoring the affected environment. This principle supports accurate disclosure of pollution, waste management failures and environmental liabilities.

Major Principles of Sustainability Reporting

Environmental responsibility: Disclosure of energy consumption, water usage, emissions and biological waste disposal.

Research ethics: Transparency concerning clinical trials, informed consent and participant protection.

Biosafety: Reporting of measures for handling genetically modified organisms and hazardous biological materials.

Social responsibility: Disclosure of employee welfare, workplace safety, human rights and community impact.

Corporate governance: Accurate reporting, independent assurance where applicable and accountability for misleading disclosures.

Supply-chain responsibility: Monitoring environmental and social practices of suppliers and manufacturing partners.

Conclusion

Sustainability reporting in biotechnology is essential for combining scientific development with environmental protection, social responsibility and corporate accountability. India's BRSR framework, Companies Act, 2013 and environmental legislation provide the regulatory foundation. Decisions such as Alembic Pharmaceuticals, Vellore Citizens' Welfare Forum and M.C. Mehta reinforce the importance of sustainable industrial practices. Biotechnology companies must ensure that their sustainability disclosures are accurate, transparent and supported by verifiable information.